- Corporate Officers - H
- Henderson Lori M.
Insider Trading History of Henderson Lori M.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henderson Lori M. since 2006.
This trader's CIK number is 1221127.
At the time of last reporting, Henderson Lori M. was the General Counsel and Secretary of Moderna, Inc.. (stock ticker symbol MRNA).
Also see all insider trading activities at Moderna, Inc..
Note that in the past
HENDERSON LORI M. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Moderna, Inc. (MRNA) by Henderson Lori M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | MRNA | 0 | $0 | 151,800 | $22,479,794 | 151,800 | $3,137,970 |
2020 | MRNA | 0 | $0 | 160,000 | $10,757,856 | 160,000 | $2,376,000 |
Yearly summary of insider trading at Moldflow Corp (MFLO) by Henderson Lori M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2008 | MFLO | 0 | $0 | 1,667 | $22,087 | 5,667 | $93,207 |
2007 | MFLO | 0 | $0 | 20,563 | $325,573 | 44,833 | $243,078 |
2006 | MFLO | 0 | $0 | 1,000 | $11,660 | 10,000 | $46,200 |
Yearly summary of insider trading at Albany Molecular Research Inc (AMRI) by Henderson Lori M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | AMRI | 0 | $0 | 6,000 | $102,000 | 0 | $0 |
2014 | AMRI | 0 | $0 | 46,000 | $866,804 | 30,000 | $146,100 |
2011 | AMRI | 5,900 | $14,573 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Henderson Lori M.:
1. Moderna, Inc. (MRNA)
2. Moldflow Corp (MFLO)
3. Albany Molecular Research Inc (AMRI)
Table 1. Insider trading of Moderna, Inc. (MRNA) by Henderson Lori M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-05-27 | MRNA | Option Ex | 6,600 | 14.85 | 98,010 |
2021-05-27 | MRNA | Sale | 6,600 | 174.20 | 1,149,720 |
2021-05-25 | MRNA | Option Ex | 6,600 | 14.85 | 98,010 |
2021-05-25 | MRNA | Sale | 6,600 | 166.58 | 1,099,428 |
2021-05-20 | MRNA | Option Ex | 6,600 | 14.85 | 98,010 |
2021-05-20 | MRNA | Sale | 6,600 | 159.92 | 1,055,472 |
2021-05-18 | MRNA | Sale | 6,600 | 160.16 | 1,057,056 |
2021-05-18 | MRNA | Option Ex | 6,600 | 14.85 | 98,010 |
2021-05-13 | MRNA | Sale | 6,600 | 152.60 | 1,007,160 |
2021-05-13 | MRNA | Option Ex | 6,600 | 14.85 | 98,010 |
2021-05-11 | MRNA | Option Ex | 6,600 | 17.89 | 118,074 |
2021-05-11 | MRNA | Sale | 6,600 | 151.31 | 998,646 |
2021-05-06 | MRNA | Sale | 6,600 | 147.82 | 975,612 |
2021-05-06 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-27 | MRNA | Sale | 6,600 | 178.29 | 1,176,714 |
2021-04-27 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-22 | MRNA | Sale | 6,600 | 168.26 | 1,110,516 |
2021-04-22 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-20 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-20 | MRNA | Sale | 6,600 | 160.32 | 1,058,112 |
2021-04-15 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-15 | MRNA | Sale | 6,600 | 158.76 | 1,047,815 |
2021-04-13 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-13 | MRNA | Sale | 6,600 | 146.62 | 967,692 |
2021-04-08 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-08 | MRNA | Sale | 6,600 | 132.85 | 876,810 |
2021-04-06 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-06 | MRNA | Sale | 6,600 | 130.01 | 858,065 |
2021-04-01 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-04-01 | MRNA | Sale | 6,600 | 132.51 | 874,565 |
2021-03-30 | MRNA | Sale | 6,600 | 123.30 | 813,780 |
2021-03-30 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-03-25 | MRNA | Sale | 6,600 | 126.88 | 837,408 |
2021-03-25 | MRNA | Option Ex | 6,600 | 20.93 | 138,138 |
2021-03-18 | MRNA | Option Ex | 6,600 | 23.43 | 154,638 |
2021-03-18 | MRNA | Sale | 6,600 | 144.39 | 952,973 |
2021-03-16 | MRNA | Option Ex | 6,600 | 25.93 | 171,138 |
2021-03-16 | MRNA | Sale | 6,600 | 148.50 | 980,100 |
2021-03-11 | MRNA | Option Ex | 6,600 | 25.93 | 171,138 |
2021-03-11 | MRNA | Sale | 6,600 | 133.29 | 879,714 |
2021-03-09 | MRNA | Option Ex | 6,600 | 25.93 | 171,138 |
2021-03-09 | MRNA | Sale | 6,600 | 127.11 | 838,926 |
2021-03-04 | MRNA | Option Ex | 6,600 | 25.93 | 171,138 |
2021-03-04 | MRNA | Sale | 6,600 | 128.58 | 848,628 |
2021-03-02 | MRNA | Option Ex | 6,600 | 25.93 | 171,138 |
2021-03-02 | MRNA | Sale | 6,600 | 153.77 | 1,014,882 |
2020-10-21 | MRNA | Sale | 32,000 | 70.12 | 2,243,936 |
2020-10-21 | MRNA | Option Ex | 32,000 | 14.85 | 475,200 |
2020-06-18 | MRNA | Option Ex | 64,000 | 14.85 | 950,400 |
2020-06-18 | MRNA | Sale | 64,000 | 63.03 | 4,033,920 |
2020-05-20 | MRNA | Option Ex | 64,000 | 14.85 | 950,400 |
2020-05-20 | MRNA | Sale | 64,000 | 70.00 | 4,480,000 |
Table 2. Insider trading of Moldflow Corp (MFLO) by Henderson Lori M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2008-06-18 | MFLO | Option Ex | 4,000 | 17.88 | 71,520 |
2008-01-30 | MFLO | Sale | 1,667 | 13.25 | 22,087 |
2008-01-30 | MFLO | Option Ex | 1,667 | 13.01 | 21,687 |
2007-12-11 | MFLO | Sale | 10,163 | 16.40 | 166,673 |
2007-05-17 | MFLO | Sale | 2,565 | 18.81 | 48,247 |
2007-05-15 | MFLO | Option Ex | 22,000 | 4.62 | 101,640 |
2007-02-15 | MFLO | Option Ex | 18,000 | 4.62 | 83,160 |
2007-02-15 | MFLO | Sale | 1,208 | 14.27 | 17,238 |
2007-02-16 | MFLO | Sale | 1,794 | 14.21 | 25,498 |
2007-01-17 | MFLO | Option Ex | 4,000 | 13.32 | 53,280 |
2007-01-17 | MFLO | Sale | 4,000 | 14.09 | 56,360 |
2007-01-03 | MFLO | Option Ex | 833 | 6.00 | 4,998 |
2007-01-03 | MFLO | Sale | 833 | 13.88 | 11,557 |
2006-11-15 | MFLO | Option Ex | 10,000 | 4.62 | 46,200 |
2006-09-15 | MFLO | Sale | 1,000 | 11.66 | 11,660 |
Table 3. Insider trading of Albany Molecular Research Inc (AMRI) by Henderson Lori M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-11-16 | AMRI | Sale | 6,000 | 17.00 | 102,000 |
2014-10-01 | AMRI | Sale | 1,000 | 21.48 | 21,480 |
2014-09-02 | AMRI | Sale | 2,500 | 19.56 | 48,900 |
2014-08-12 | AMRI | Option Ex | 30,000 | 4.87 | 146,100 |
2014-08-12 | AMRI | Sale | 30,000 | 19.05 | 571,500 |
2014-08-01 | AMRI | Sale | 2,500 | 18.56 | 46,400 |
2014-07-01 | AMRI | Sale | 2,500 | 20.62 | 51,550 |
2014-06-02 | AMRI | Sale | 2,500 | 16.32 | 40,800 |
2014-05-01 | AMRI | Sale | 2,500 | 15.73 | 39,325 |
2014-04-01 | AMRI | Sale | 2,500 | 18.74 | 46,849 |
2011-12-07 | AMRI | Buy | 5,900 | 2.47 | 14,573 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Henderson Lori M.
(General Counsel and Secretary of Moderna, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.